TTM
$542.70M
YoY change
+0.2%
5Y CAGR
+7.4%
Peak year (2021)
$661.80M
Cumulative net income
$5.30B
Net Income history chart for West Pharmaceutical Services (WST) from 1985 to 2025
Latest: $493.70M
Net Income growth chart for West Pharmaceutical Services (WST) from 1985 to 2025
Latest: +0.2%
Net Income history table for West Pharmaceutical Services (WST) from 1985 to 2025
| 2025 | $493.70M | +0.2% | +$1.00M | ||
| 2024 | $492.70M | -17.0% | −$100.70M | ||
| 2023 | $593.40M | +1.3% | +$7.50M | ||
| 2022 | $585.90M | -11.5% | −$75.90M | ||
| 2021 | $661.80M | +91.2% | +$315.60M | ||
| 2020 | $346.20M | +43.2% | +$104.50M | ||
| 2019 | $241.70M | +16.8% | +$34.80M | ||
| 2018 | $206.90M | +37.3% | +$56.20M | ||
| 2017 | $150.70M | +4.9% | +$7.10M | ||
| 2016 | $143.60M | +50.2% | +$48.00M | ||
| 2015 | $95.60M | -24.8% | −$31.50M | ||
| 2014 | $127.10M | +13.2% | +$14.80M | ||
| 2013 | $112.30M | +39.2% | +$31.60M | ||
| 2012 | $80.70M | +6.9% | +$5.20M | ||
| 2011 | $75.50M | +15.6% | +$10.20M | ||
| 2010 | $65.30M | -10.1% | −$7.30M | ||
| 2009 | $72.60M | -15.6% | −$13.40M | ||
| 2008 | $86.00M | +21.6% | +$15.30M | ||
| 2007 | $70.70M | +5.4% | +$3.60M | ||
| 2006 | $67.10M | +47.1% | +$21.50M | ||
| 2005 | $45.60M | +135.1% | +$26.20M | ||
| 2004 | $19.40M | -39.2% | −$12.50M | ||
| 2003 | $31.90M | +73.4% | +$13.50M | ||
| 2002 | $18.40M | -453.8% | +$23.60M | ||
| 2001 | −$5.20M | -425.0% | −$6.80M | ||
| 2000 | $1.60M | -95.9% | −$37.10M | ||
| 1999 | $38.70M | +477.6% | +$32.00M | ||
| 1998 | $6.70M | -84.9% | −$37.70M | ||
| 1997 | $44.40M | +170.7% | +$28.00M | ||
| 1996 | $16.40M | -42.9% | −$12.30M | ||
| 1995 | $28.70M | +5.1% | +$1.40M | ||
| 1994 | $27.30M | +16.2% | +$3.80M | ||
| 1993 | $23.50M | +19.3% | +$3.80M | ||
| 1992 | $19.70M | -331.8% | +$28.20M | ||
| 1991 | −$8.50M | -297.7% | −$12.80M | ||
| 1990 | $4.30M | -79.2% | −$16.40M | ||
| 1989 | $20.70M | +19.0% | +$3.30M | ||
| 1988 | $17.40M | +27.0% | +$3.70M | ||
| 1987 | $13.70M | -19.4% | −$3.30M | ||
| 1986 | $17.00M | +13.3% | +$2.00M | ||
| 1985 | $15.00M | — | — |
- 2025$493.70M+0.2%
- 2024$492.70M-17.0%
- 2023$593.40M+1.3%
- 2022$585.90M-11.5%
- 2021$661.80M+91.2%
- 2020$346.20M+43.2%
- 2019$241.70M+16.8%
- 2018$206.90M+37.3%
- 2017$150.70M+4.9%
- 2016$143.60M+50.2%
- 2015$95.60M-24.8%
- 2014$127.10M+13.2%
- 2013$112.30M+39.2%
- 2012$80.70M+6.9%
- 2011$75.50M+15.6%
- 2010$65.30M-10.1%
- 2009$72.60M-15.6%
- 2008$86.00M+21.6%
- 2007$70.70M+5.4%
- 2006$67.10M+47.1%
- 2005$45.60M+135.1%
- 2004$19.40M-39.2%
- 2003$31.90M+73.4%
- 2002$18.40M-453.8%
- 2001−$5.20M-425.0%
- 2000$1.60M-95.9%
- 1999$38.70M+477.6%
- 1998$6.70M-84.9%
- 1997$44.40M+170.7%
- 1996$16.40M-42.9%
- 1995$28.70M+5.1%
- 1994$27.30M+16.2%
- 1993$23.50M+19.3%
- 1992$19.70M-331.8%
- 1991−$8.50M-297.7%
- 1990$4.30M-79.2%
- 1989$20.70M+19.0%
- 1988$17.40M+27.0%
- 1987$13.70M-19.4%
- 1986$17.00M+13.3%
- 1985$15.00M—
Net Income values are taken from West Pharmaceutical Services's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's current net income (TTM) is $542.70M. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of West Pharmaceutical Services (WST) net income is $493.70M – edged up 0.2% year-over-year.
Across 2020–2025 (5 years), West Pharmaceutical Services net income produced a CAGR of +7.4% – with mixed annual results across the window.
Between 2021 and 2025, West Pharmaceutical Services net income declined 25.4%, falling from $661.80M to $493.70M.
The highest annual net income of $661.80M was reported in 2021. The lowest in the available history was −$8.50M in 1991.
West Pharmaceutical Services Net Income by Year
West Pharmaceutical Services Net Income 2025: $493.70M
West Pharmaceutical Services net income in 2025 was $493.70M, edged up 0.2% from 2024.
West Pharmaceutical Services Net Income 2024: $492.70M
2024's net income for West Pharmaceutical Services came in at $492.70M, declined 17.0% below 2023.
West Pharmaceutical Services Net Income 2023: $593.40M
West Pharmaceutical Services posted net income of $593.40M in 2023, edged up 1.3% from 2022.
West Pharmaceutical Services Net Income 2022: $585.90M
In 2022, West Pharmaceutical Services reported net income of $585.90M, declined 11.5% below 2021.
West Pharmaceutical Services Net Income 2021: $661.80M
West Pharmaceutical Services net income in 2021 was $661.80M.
See more financial history for West Pharmaceutical Services (WST).
Sector peers by Net Income
Healthcare peers of West Pharmaceutical Services (WST), ranked by their latest net income
| $26.80B | |
| $20.64B | |
| $18.25B | |
| $15.97B | |
| $12.06B | |
| $10.26B | |
| $7.71B | |
| $4.23B |
- $26.80B
- $20.64B
- $18.25B
- $15.97B
- $12.06B
- $10.26B
- $7.71B
- $4.23B
Frequently asked questions
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation